- QD279: Hyperpigmentation in Lupus (Dr. Jack Cush) https://youtu.be/xA9nvuadhCg - QD280: Polar Opposite Approaches for Lupus (Dr. Eric Dein) https://youtu.be/zCnF1rgAapk - QD281: Refractory Renal SLE (Dr. Jack Cush) https://youtu.be/dHS8etnZsRw
Dr. Jack Cush reviews the news and journal reports from RheumNow.com - including views on the vagus nerve, NPSLE and CAR-T mania.
In this one-hour webinar, panelists discussed antiphospholipid syndrome, including diagnosis, labs, treatment approaches and more. Panelists Dr. Shruti Chaturvedi, Dr. Jason Knight, Dr. Cassy Sims and Dr. Jack Cush
Dr. Jack Cush reviews the news, journal and regulatory reports from this week on RheumNow.com. Interesting trends and results with prednisone in lupus, cannabis in RA and opioid deaths too!
Discussion of the diagnosis, management, and latest insights into cutaneous manifestations of SLE. Panelists: Dr. Victoria P. Werth, Dr. Matilda Nicholas; Dr. Anthony Fernandez; and, Dr. Christopher Richardson.
Dr. Jack Cush reviews the news, journal reports and lupus highlights from the past week on RheumNow.com. Triple positivity, the gut and CRPS, and hope for better outcomes with Vitamin D therapy.
In this first webinar of RheumNow's Lupus Unlocked campaign, Journal Club discussed two articles: Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis. Furie R, et al. NEJM. 2025 Feb 7. doi: 10.1056 Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1) Rovin BH. Lancet. 2021 May 29;397(10289) Speakers: Brad Rovin, MD Richard Furie, MD Jack Cush, MD
Dr. Jack Cush reviews the news, articles and drug approvals from the past week on RheumNow.com. This podcast marks the beginning of our Lupus Campaign called "Lupus Unlocked: Keys to Mastery". This months campaign on Lupus is sponsored by Aurinia.
Listen as coinvestigator and rheumatologist Dr. Andrea Rubbert-Roth reviews this Phase 3 trial of a JAKi in patients with giant cell arteritis. Dr. Rubbert-Roth discusses the latest results, including efficacy and safety outcomes.
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Should we believe the reviews and metanalyses?
Dr. Jack Cush reviews the news and Journal reports from this week on RheumNow.com. Osteoarthritis patients have unique risks and synovial fluid WBC numbers can tell you when to worry about septic arthritis in gout and pseudogout patients.
Dr. Jack Cush reviews the news, journal reports and regulatory approvals from this past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. **Correction: a Tweet from 3/18 podcast, had incorrect information. Late Breaking abstract from 2025 Amer. Acad. Dermatology (AAD) on the Phase 3 ICONIC-LEAD study showed J&J's oral IL-23 inhibitor (icotrokinra) was superior to PLACEBO (not deucravacitinib as reported) in skin clearance (65% vs 8%) & PASI90 (50% v 4%) at Wk 16 (NOT 15) in 684 moderate-to-severe plaque PsO pts https://buff.ly/dMbTbML...
Rheumatologist Dr. Walter Maksymowych discusses the role of biomarkers in RA care, with a focus on 14-3-3eta as a modifiable marker for diagnosis and monitoring disease progression.
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com. Listen in for 2 new case questions - Ask Cush Anything.
Dr Jack Cush and his podcast friends are out to change the world. Here is his weekly review of the news and journal reports from the past week on RheumNow.com
Hear from rheumatologist Stanley J. Naides MD, FACP, FACR, as he details the clinical features of autoimmune myositis, the associated phenotypes and autoantibodies, plus the methodologies and testing options to support a myositis diagnosis.
Two leading rheumatologists share insights into why RF levels are important to consider when identifying treatment options for patients with RA.
Dr. Jack Cush reviews the news, journal reports and regulatory actions from the past week on RheumNow.com
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. Opioid deaths are down, IL-33 levels are up and Weight loss is in the news again this week!
Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com
Dr. Jack Cush reviews highlights from RheumNow Live 2025 held in Dallas, TX on Feb. 8-9, 2025
Dr. Jack Cush reviews the news, regulatory and journal reports from the past week on RheumNow.com
QD276 - New Palmoplantar Psoriasis and PsA https://youtu.be/GJmY27xA1MM QD277 - dsDNA without Lupus https://youtu.be/daL70sBh8ss QD278 - Recurrent Acute Oligoarthritis https://youtu.be/Xp2ZNBPN1o8 Features Dr. Jack Cush. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. We have two call-in cases on "Ask Cush Anything" Be sure to join in the fun at RNL 2025 next weekend - Gong Show Karaoke; what will you sing?
QD Clinic 273 - ANA Negative Lupus https://youtu.be/g0W9aBRuDcQ Pregnant ANA negative SLE (?) patients with Sjogrens and FM - what to do? QD274 - Undiagnosed Autoinflammatory https://youtu.be/hUkYi1gKJOM Autoinflammatory or Still's disease - does this matter? QD275 - Past DIagnoses https://youtu.be/1f4HYhvVGNA When patients cling to a past diagnosis. QD Clinics - lessons from the clinic, sponsored by RNL2025 in Dallas, TX; Feb 8 & 9, 2025 Register at RheumNow.live...
Dr. Jack Cush reviews the news and journal reports from RheumNow.com. He features Dr. Charity Dean, the Keynote speaker at RheumNow Live 2025 and why she is an inspiration. Register for RheumNow Live 2025 and hear Keynote Speaker, Dr. Charity Dean -- RheumNow.live
Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com; and pays homage to colleagues who passed away in 2024.
